Australian Clinical Labs Limited (ASX:ACL)

Australian Clinical Labs Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	593	503	694	922	686	-
Market Cap Growth	18.13%	-27.51%	-24.69%	34.33%	-	-
Enterprise Value	887	805	1,001	1,160	940	-
Last Close Price	3.01	2.41	3.19	3.82	2.76	-
PE Ratio	19.60	21.03	19.34	5.17	11.37	-
Forward PE	15.69	13.83	15.92	9.64	7.42	-
PS Ratio	0.81	0.72	1.00	0.93	1.06	-
PB Ratio	3.51	2.83	4.02	3.96	8.38	-
P/TBV Ratio	152.45	39.99	95.82	13.75	-	-
P/FCF Ratio	3.70	3.29	5.08	3.51	4.75	-
P/OCF Ratio	3.55	3.15	4.83	3.25	4.46	-
PEG Ratio	1.01	3.00	-	-	0.63	-
EV/Sales Ratio	1.22	1.16	1.44	1.17	1.45	-
EV/EBITDA Ratio	4.46	10.55	12.56	4.05	6.80	-
EV/EBIT Ratio	13.36	12.87	15.35	4.24	7.34	-
EV/FCF Ratio	5.53	5.26	7.32	4.42	6.51	-
Debt / Equity Ratio	1.87	1.74	1.83	1.13	3.71	3.21
Debt / EBITDA Ratio	1.58	1.62	1.68	0.69	1.41	2.30
Debt / FCF Ratio	1.97	2.02	2.31	1.00	2.11	2.40
Asset Turnover	1.25	1.19	1.16	1.79	1.52	1.89
Inventory Turnover	27.75	27.72	25.32	32.71	32.71	34.66
Quick Ratio	0.45	0.52	0.51	0.53	0.60	0.73
Current Ratio	0.59	0.64	0.62	0.64	0.71	0.83
Return on Equity (ROE)	18.56%	13.84%	17.79%	113.46%	80.04%	85.58%
Return on Assets (ROA)	7.11%	6.67%	6.75%	30.79%	18.82%	4.44%
Return on Capital (ROIC)	8.51%	8.01%	8.29%	38.89%	23.67%	6.18%
Return on Capital Employed (ROCE)	17.60%	16.20%	16.70%	68.00%	40.20%	8.00%
Earnings Yield	5.17%	4.76%	5.17%	19.34%	8.80%	-
FCF Yield	27.05%	30.42%	19.70%	28.51%	21.04%	-
Dividend Yield	4.07%	4.97%	4.38%	13.89%	5.16%	-
Payout Ratio	77.78%	83.35%	269.85%	13.59%	69.57%	-
Buyback Yield / Dilution	0.78%	0.82%	0.18%	-32.47%	-4.65%	-
Total Shareholder Return	4.85%	5.79%	4.57%	-18.58%	0.51%	-

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.